Related Experiment Videos
The caries vaccine: a growing prospect.
1Department of Oral Medicine and Pathology, Guy's Hospital, London.
Dental Update
|April 15, 2000
Summary
A new topical vaccine for dental caries, caused by Streptococcus mutans, is in phase II trials. This injection-free vaccine, produced using green plants, offers safe, long-term protection and may be available within 6 years.
Area of Science:
- Biotechnology
- Vaccinology
- Microbiology
Background:
- Dental caries, primarily caused by Streptococcus mutans, remains a significant global health issue.
- Previous vaccine development efforts for dental caries have faced challenges.
- Recent advances in molecular biology and genetic engineering have opened new avenues for vaccine design.
Purpose of the Study:
- To describe a novel topical vaccine targeting Streptococcus mutans.
- To highlight the potential of plant-based vaccine production.
- To report on the current status of vaccine development, including clinical trials.
Main Methods:
- Development of a topical vaccine formulation against Streptococcus mutans.
- Utilizing green plants as a production system for vaccine antigens.
- Conducting phase II clinical trials to assess safety and efficacy.
Main Results:
- The vaccine is administered topically, eliminating the need for injections.
- The vaccine has demonstrated safety and effectiveness in preliminary studies.
- Long-term protection, lasting up to one year, has been observed.
Conclusions:
- A plant-produced, topical vaccine against dental caries shows significant promise.
- The vaccine is currently in phase II clinical trials.
- Commercial availability is anticipated within 5 to 6 years, offering a novel preventive strategy for dental caries.